美国 · 股市与财经 · Fortune
Psychedelic medicine is approaching a turning point. The U.S. needs the right infrastructure to be ready
Today’s psychedelics bear little resemblance to 1970s counterparts. These medicines undergo rigorous clinical trials and licensed manufacturing processes.
在 Fortune 阅读全文 登录后可收藏MediaNews 仅展示媒体发布的标题和摘要,全文请在出版方网站阅读。 (fortune.com)





